Payer Roundup—Insurance brokers offered gifts, cash for selling employer health plans

Health insurance benefits form
Insurance companies are offering big payouts to top-selling brokers. (Getty/michaelquirk)

Insurance brokers offered gifts, cash for selling employer health plans

Insurance companies are offering big payouts to top-selling brokers. Bonuses can be as high as $100,000 per group and incentives include trips and experiences, reported National Public Radio. 

While the commissions technically come from the insurance companies, the cost is actually built into the premiums that the employers are paying. Therefore, industry payments can heavily influence which plans brokers push to advertise when making a sale. 

"If you want to draw a straight conclusion: It has been in the best interest of a broker, from a financial point of view, to keep that premium moving up," Jeffrey Hogan, a regional manager in Connecticut for a national insurance brokerage, told NPR. (NPR)


13th Partnering with ACOS & IDNS Summit

This two-day summit taking place on June 10–11, 2019, offers a unique opportunity to have invaluable face-to-face time with key executives from various ACOs and IDNs from the entire nation – totaling over 3.5 million patients served in 2018. Exclusively at this summit, attendees are provided with inside information and data from case studies on how to structure an ACO/IDN pitch, allowing them to gain the tools to position their organization as a “strategic partner” to ACOs and IDNs, rather than a merely a “vendor.”

U.S. joins false claims suit against Arriva for Medicare kickbacks

The U.S. has joined a False Claims lawsuit against Arriva Medical LLC and its parent company, Alere Inc. The Department of Justice alleges that Arriva filed false claims to Medicare for medically unnecessary glucometers and paid kickbacks to Medicare beneficiaries in the form of copayment waivers and glucometers. 

Arriva, a mail-order diabetic testing supply company, was acquired by Alere, a medical device company, in 2011. Both entities were acquired by Abbott Laboratories in September 2017, after the alleged conduct occurred. As a result, in October 2016, the Centers for Medicare & Medicaid Services revoked Arriva’s billing number and Arriva stopped operating altogether in December of 2017.

“Medicare rules bar payment for medically unnecessary services and supplies,” Derrick L. Jackson, special agent in charge at the U.S. Department of Health and Human Services' Office of Inspector General, said. “Such schemes only benefit suppliers billing for products that patients neither want nor need.” (Announcement)

CMS launches podcast for beneficiaries

The Centers for Medicare & Medicaid Services (CMS) has launched a podcast discussing agency updates and policies via a new platform.

The show, "CMS: Beyond the Policy," was created in direct response to stakeholders’ suggestions for a modern, user-friendly channel for relaying information about agency programs. Episodes will feature a range of subject-matter experts and CMS Administrator Seema Verma. The inaugural episode will focus on evaluation and management coding. (Announcement)

Suggested Articles

Humana is teaming up with telehealth company Doctor on Demand to launch a new virtual care model focused on primary care.

A federal judge in Pennsylvania has tossed UPMC’s class action suit against the state’s attorney general.

Seema Verma said Thursday that while the Trump administration has focused on voluntary payment models to date, that is likely to change.